MedPath

Comparison of Wire Assisted Percutaneous Balloon Mitral Valvulotomy With Standard Inoue Balloon Valvulotomy

Not Applicable
Completed
Conditions
Rheumatic Heart Disease
Registration Number
NCT06150274
Lead Sponsor
Helse Stavanger HF
Brief Summary

The goal of this randomised study is comparison of wire assisted balloon mitral valvulotomy to standard Inoue balloon technique on patients with rheumatic mitral stenosis. The main question it aims to answer is whether procedure time is reduced using the wire assisted method. Participants will be randomized to one of the two methods.

Detailed Description

Background: Rheumatic valvular disease, a chronic sequela of acute rheumatic fever, is a leading cause of cardiovascular mortality in developing countries. The available options of management include surgical treatment and balloon valvulotomy. Among various forms of rheumatic valvular lesions, severe mitral stenosis with favorable morphology can be successfully treated by balloon valvulotomy.

Methods: The study is a randomized controlled trial with intervention in both arms.

The objective of this study is to compare procedural time as a primary end point.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • significant mitral stenosis
  • low Wilkins score (< 10)
  • mitral regurgitation grade not more than 2
Exclusion Criteria
  • high Wilkins score (>10)
  • unfavourable anatomy
  • presence of left appendage thrombus
  • non-conclusive periprocedural trans oesophageal echocardiography imaging

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Reduction in procedure durationday 1

procedure time in minutes

Secondary Outcome Measures
NameTimeMethod
procedure failureday 1

failed procedure after lengthy attempt

Trial Locations

Locations (1)

Tikur Anbessa Specialized Hospital

🇪🇹

Addis Ababa, Addis Abeba, Ethiopia

Tikur Anbessa Specialized Hospital
🇪🇹Addis Ababa, Addis Abeba, Ethiopia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.